Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	poly(A) binding	KHDRBS1 HNRNPDL DDX3X	3.28e-07	29	10	3	GO:0008143
GeneOntologyMolecularFunction	poly-purine tract binding	KHDRBS1 HNRNPDL DDX3X	6.97e-07	37	10	3	GO:0070717
GeneOntologyMolecularFunction	mRNA binding	KHDRBS1 DDX3X HNRNPR DDX3Y RBMXL3	1.09e-05	694	10	5	GO:0003729
GeneOntologyMolecularFunction	single-stranded RNA binding	KHDRBS1 HNRNPDL DDX3X	1.95e-05	111	10	3	GO:0003727
GeneOntologyMolecularFunction	RNA helicase activity	DDX3X DDX3Y	6.64e-04	78	10	2	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX3X DDX3Y	6.99e-04	80	10	2	GO:0008186
GeneOntologyMolecularFunction	signaling adaptor activity	KHDRBS1 DDX3X	1.80e-03	129	10	2	GO:0035591
GeneOntologyMolecularFunction	helicase activity	DDX3X DDX3Y	2.69e-03	158	10	2	GO:0004386
GeneOntologyBiologicalProcess	RNA splicing	KHDRBS1 FAM98A HNRNPR RBMXL3	6.48e-05	502	10	4	GO:0008380
GeneOntologyBiologicalProcess	positive regulation of translational initiation	KHDRBS1 DDX3X	8.53e-05	29	10	2	GO:0045948
GeneOntologyBiologicalProcess	RNA processing	KHDRBS1 FAM98A DDX3X HNRNPR RBMXL3	3.73e-04	1500	10	5	GO:0006396
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	KHDRBS1 HNRNPR RBMXL3	5.68e-04	358	10	3	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	KHDRBS1 HNRNPR RBMXL3	5.68e-04	358	10	3	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	KHDRBS1 HNRNPR RBMXL3	5.87e-04	362	10	3	GO:0000375
GeneOntologyBiologicalProcess	mRNA metabolic process	KHDRBS1 HNRNPDL HNRNPR RBMXL3	6.57e-04	917	10	4	GO:0016071
GeneOntologyBiologicalProcess	regulation of translational initiation	KHDRBS1 DDX3X	8.47e-04	91	10	2	GO:0006446
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	KHDRBS1 HNRNPR RBMXL3	1.06e-03	443	10	3	GO:1903311
GeneOntologyBiologicalProcess	positive regulation of plasma membrane bounded cell projection assembly	FAM98A FRMD7	1.54e-03	123	10	2	GO:0120034
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	KHDRBS1 RBMXL3	1.69e-03	129	10	2	GO:0048024
GeneOntologyBiologicalProcess	translational initiation	KHDRBS1 DDX3X	1.77e-03	132	10	2	GO:0006413
GeneOntologyBiologicalProcess	mRNA processing	KHDRBS1 HNRNPR RBMXL3	1.98e-03	551	10	3	GO:0006397
GeneOntologyBiologicalProcess	positive regulation of translation	KHDRBS1 DDX3X	2.31e-03	151	10	2	GO:0045727
GeneOntologyBiologicalProcess	positive regulation of cellular component biogenesis	FAM98A FRMD7 DDX3X	2.31e-03	582	10	3	GO:0044089
GeneOntologyBiologicalProcess	regulation of mRNA processing	KHDRBS1 RBMXL3	2.52e-03	158	10	2	GO:0050684
GeneOntologyCellularComponent	pole plasm	DDX3X DDX3Y	8.30e-05	29	10	2	GO:0045495
GeneOntologyCellularComponent	germ plasm	DDX3X DDX3Y	8.30e-05	29	10	2	GO:0060293
GeneOntologyCellularComponent	P granule	DDX3X DDX3Y	8.30e-05	29	10	2	GO:0043186
GeneOntologyCellularComponent	spliceosomal complex	HNRNPR RBMXL3	4.49e-03	215	10	2	GO:0005681
GeneOntologyCellularComponent	growth cone	FRMD7 HNRNPR	5.79e-03	245	10	2	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	FRMD7 HNRNPR	6.16e-03	253	10	2	GO:0030427
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	DDX3X DDX3Y	6.94e-03	269	10	2	GO:0036464
GeneOntologyCellularComponent	ribonucleoprotein granule	DDX3X DDX3Y	7.86e-03	287	10	2	GO:0035770
GeneOntologyCellularComponent	ribonucleoprotein complex	DDX3X HNRNPR RBMXL3	1.65e-02	1194	10	3	GO:1990904
GeneOntologyCellularComponent	distal axon	FRMD7 HNRNPR	1.74e-02	435	10	2	GO:0150034
MousePheno	abnormal bone mineral density of femur	KHDRBS1 IBSP	4.14e-04	63	7	2	MP:0020009
MousePheno	abnormal placental labyrinth vasculature morphology	DDX3X SS18	1.02e-03	99	7	2	MP:0008803
MousePheno	abnormal bone remodeling	KHDRBS1 IBSP	3.25e-03	178	7	2	MP:0002998
MousePheno	abnormal placenta vasculature	DDX3X SS18	3.77e-03	192	7	2	MP:0003231
MousePheno	abnormal placenta labyrinth morphology	DDX3X SS18	3.84e-03	194	7	2	MP:0001716
Domain	DEAD_ATP_HELICASE	DDX3X DDX3Y	1.19e-04	31	10	2	PS00039
Domain	RNA-helicase_DEAD-box_CS	DDX3X DDX3Y	1.35e-04	33	10	2	IPR000629
Domain	RRM_1	HNRNPDL HNRNPR RBMXL3	1.54e-04	208	10	3	PF00076
Domain	RNA_helicase_DEAD_Q_motif	DDX3X DDX3Y	1.70e-04	37	10	2	IPR014014
Domain	Q_MOTIF	DDX3X DDX3Y	1.70e-04	37	10	2	PS51195
Domain	RRM	HNRNPDL HNRNPR RBMXL3	1.75e-04	217	10	3	SM00360
Domain	RRM_dom	HNRNPDL HNRNPR RBMXL3	2.00e-04	227	10	3	IPR000504
Domain	RRM	HNRNPDL HNRNPR RBMXL3	2.08e-04	230	10	3	PS50102
Domain	-	HNRNPDL HNRNPR RBMXL3	2.47e-04	244	10	3	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	HNRNPDL HNRNPR RBMXL3	2.91e-04	258	10	3	IPR012677
Domain	DEAD	DDX3X DDX3Y	6.64e-04	73	10	2	PF00270
Domain	DEAD/DEAH_box_helicase_dom	DDX3X DDX3Y	6.64e-04	73	10	2	IPR011545
Domain	Helicase_C	DDX3X DDX3Y	1.42e-03	107	10	2	PF00271
Domain	HELICc	DDX3X DDX3Y	1.42e-03	107	10	2	SM00490
Domain	Helicase_C	DDX3X DDX3Y	1.45e-03	108	10	2	IPR001650
Domain	DEXDc	DDX3X DDX3Y	1.47e-03	109	10	2	SM00487
Domain	HELICASE_CTER	DDX3X DDX3Y	1.47e-03	109	10	2	PS51194
Domain	HELICASE_ATP_BIND_1	DDX3X DDX3Y	1.47e-03	109	10	2	PS51192
Domain	Helicase_ATP-bd	DDX3X DDX3Y	1.50e-03	110	10	2	IPR014001
Pathway	WP_MRNA_PROCESSING	HNRNPDL DDX3X HNRNPR RBMXL3	6.53e-05	451	8	4	MM15946
Pathway	WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY	DDX3X DDX3Y	4.91e-04	60	8	2	M39583
Pathway	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	DDX3X DDX3Y	6.87e-04	71	8	2	M15913
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR	6.12e-10	421	10	6	34650049
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR DDX3Y	1.28e-09	954	10	7	36373674
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	5.49e-09	260	10	5	36199071
Pubmed	Proteomic dissection of the von Hippel-Lindau (VHL) interactome.	HNRNPDL DDX3X HNRNPR DDX3Y	1.23e-08	98	10	4	21942715
Pubmed	SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation.	KHDRBS1 FAM98A DDX3X HNRNPR	3.85e-08	130	10	4	32905556
Pubmed	Landscape of the SOX2 protein-protein interactome.	KHDRBS1 FAM98A DDX3X HNRNPR	4.61e-08	136	10	4	21280222
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	6.76e-08	430	10	5	38172120
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	KHDRBS1 HNRNPDL HNRNPR RBMXL3	7.41e-08	153	10	4	28225217
Pubmed	An azoospermic factor gene, Ddx3y and its paralog, Ddx3x are dispensable in germ cells for male fertility.	DDX3X DDX3Y	7.44e-08	2	10	2	30613052
Pubmed	Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis.	DDX3X DDX3Y	7.44e-08	2	10	2	34437837
Pubmed	Gene structure of the human DDX3 and chromosome mapping of its related sequences.	DDX3X DDX3Y	7.44e-08	2	10	2	11710523
Pubmed	Characterization of D1Pas1, a mouse autosomal homologue of the human AZFa region DBY, as a nuclear protein in spermatogenic cells.	DDX3X DDX3Y	7.44e-08	2	10	2	11591417
Pubmed	Structural characterization and expression studies of Dby and its homologs in the mouse.	DDX3X DDX3Y	7.44e-08	2	10	2	16728723
Pubmed	Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation.	DDX3X DDX3Y	7.44e-08	2	10	2	35588748
Pubmed	Comparative Proteomics and Interactome Analysis of the SARS-CoV-2 Nucleocapsid Protein in Human and Bat Cell Lines.	KHDRBS1 HNRNPDL DDX3X HNRNPR	1.08e-07	168	10	4	39066279
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	1.24e-07	486	10	5	30940648
Pubmed	DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.	KHDRBS1 HNRNPDL DDX3X DDX3Y	1.27e-07	175	10	4	25756610
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	2.31e-07	551	10	5	34728620
Pubmed	Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.	KHDRBS1 HNRNPDL DDX3X HNRNPR	2.44e-07	206	10	4	22174317
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	HNRNPDL FAM98A DDX3X HNRNPR DDX3Y RBMXL3	2.45e-07	1153	10	6	29845934
Pubmed	SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.	KHDRBS1 HNRNPDL FAM98A HNRNPR	2.95e-07	216	10	4	37640791
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	HNRNPDL FAM98A DDX3X HNRNPR	3.35e-07	223	10	4	20020773
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	3.67e-07	605	10	5	28977666
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	4.08e-07	1257	10	6	37317656
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	KHDRBS1 HNRNPDL DDX3X HNRNPR	4.80e-07	244	10	4	29884807
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	KHDRBS1 HNRNPDL DDX3X HNRNPR	4.80e-07	244	10	4	30349055
Pubmed	Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.	KHDRBS1 DDX3X HNRNPR DDX3Y	4.88e-07	245	10	4	21182205
Pubmed	A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.	FAM98A DDX3X HNRNPR DDX3Y	5.64e-07	254	10	4	28431233
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	5.82e-07	1335	10	6	29229926
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	6.45e-07	678	10	5	30209976
Pubmed	Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3.	KHDRBS1 DDX3X	7.44e-07	5	10	2	21360055
Pubmed	Mouse erythroid cells express multiple putative RNA helicase genes exhibiting high sequence conservation from yeast to mammals.	DDX3X DDX3Y	7.44e-07	5	10	2	8144024
Pubmed	Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	7.76e-07	704	10	5	32994395
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	8.26e-07	713	10	5	29802200
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	8.97e-07	725	10	5	27025967
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	1.52e-06	807	10	5	22681889
Pubmed	USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1.	FAM98A DDX3X DDX3Y	1.67e-06	85	10	3	29228324
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	KHDRBS1 HNRNPDL DDX3X HNRNPR	1.80e-06	340	10	4	24332808
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	FAM98A DDX3X HNRNPR DDX3Y RBMXL3	1.89e-06	844	10	5	25963833
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	KHDRBS1 HNRNPDL HNRNPR RBMXL3	1.95e-06	347	10	4	16033648
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	HNRNPDL DDX3X HNRNPR	1.98e-06	90	10	3	23151878
Pubmed	Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.	FAM98A DDX3X HNRNPR	1.98e-06	90	10	3	33087562
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	KHDRBS1 FAM98A DDX3X HNRNPR	2.89e-06	383	10	4	29331416
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	2.92e-06	922	10	5	27609421
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	KHDRBS1 HNRNPDL HNRNPR DDX3Y	3.10e-06	390	10	4	17643375
Pubmed	TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules.	DDX3X DDX3Y	3.34e-06	10	10	2	18632687
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	KHDRBS1 DDX3X HNRNPR	3.54e-06	109	10	3	29511296
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	3.76e-06	971	10	5	33306668
Pubmed	Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.	KHDRBS1 DDX3X HNRNPR	4.05e-06	114	10	3	31553912
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	KHDRBS1 DDX3X HNRNPR	4.26e-06	116	10	3	21549307
Pubmed	RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.	HNRNPDL DDX3X HNRNPR DDX3Y	4.36e-06	425	10	4	21081503
Pubmed	Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.	HNRNPDL FAM98A HNRNPR	4.84e-06	121	10	3	34029587
Pubmed	Cellular proteins and HIV-1 Rev function.	KHDRBS1 DDX3X	4.90e-06	12	10	2	19149558
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	KHDRBS1 HNRNPDL DDX3X HNRNPR	5.04e-06	441	10	4	31239290
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	KHDRBS1 DDX3X HNRNPR DDX3Y	5.51e-06	451	10	4	36168627
Pubmed	Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.	HNRNPDL FAM98A HNRNPR	6.15e-06	131	10	3	28031328
Pubmed	High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.	KHDRBS1 HNRNPDL DDX3X HNRNPR	6.43e-06	469	10	4	37314180
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	HNRNPDL HNRNPR DDX3Y	6.88e-06	136	10	3	26979993
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	KHDRBS1 HNRNPDL DDX3X HNRNPR	7.05e-06	480	10	4	25437307
Pubmed	Inhibition of calpain 1 restores plasma membrane stability to pharmacologically rescued Phe508del-CFTR variant.	KHDRBS1 HNRNPDL DDX3X DDX3Y	7.52e-06	488	10	4	31324722
Pubmed	UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination.	KHDRBS1 HNRNPDL FAM98A DDX3Y	7.70e-06	491	10	4	36273042
Pubmed	Zbtb7b engages the long noncoding RNA Blnc1 to drive brown and beige fat development and thermogenesis.	DDX3X HNRNPR	7.80e-06	15	10	2	28784777
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	KHDRBS1 HNRNPDL FAM98A HNRNPR	7.89e-06	494	10	4	26831064
Pubmed	The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.	KHDRBS1 HNRNPDL HNRNPR	8.69e-06	147	10	3	28977470
Pubmed	Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model.	DDX3X DDX3Y	1.14e-05	18	10	2	35762573
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	DDX3X DDX3Y	1.14e-05	18	10	2	12023983
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	1.67e-05	1318	10	5	30463901
Pubmed	Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex.	KHDRBS1 DDX3X	1.71e-05	22	10	2	18377426
Pubmed	The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.	KHDRBS1 HNRNPDL DDX3X HNRNPR	1.74e-05	604	10	4	37616343
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	HNRNPDL DDX3X HNRNPR DDX3Y	1.84e-05	613	10	4	22268729
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	KHDRBS1 FAM98A DDX3X HNRNPR	1.87e-05	615	10	4	31048545
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	KHDRBS1 FAM98A DDX3X HNRNPR	2.00e-05	626	10	4	33644029
Pubmed	β-Actin mRNA interactome mapping by proximity biotinylation.	KHDRBS1 DDX3Y	2.05e-05	24	10	2	31189591
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	KHDRBS1 HNRNPDL DDX3X HNRNPR	2.16e-05	638	10	4	33239621
Pubmed	Functional coherence of the human Y chromosome.	DDX3X DDX3Y	2.22e-05	25	10	2	9381176
Pubmed	Profiling of Parkin-binding partners using tandem affinity purification.	HNRNPDL DDX3X HNRNPR	2.28e-05	203	10	3	24244333
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	KHDRBS1 HNRNPDL DDX3X HNRNPR	2.35e-05	652	10	4	31180492
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	DDX3X DDX3Y	2.41e-05	26	10	2	35920200
Pubmed	The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes.	KHDRBS1 DDX3X DDX3Y	2.60e-05	212	10	3	23463506
Pubmed	Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.	KHDRBS1 DDX3X	2.60e-05	27	10	2	36266428
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	KHDRBS1 HNRNPDL DDX3X DDX3Y	3.17e-05	704	10	4	29955894
Pubmed	Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.	HNRNPDL DDX3X	3.22e-05	30	10	2	21575865
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	KHDRBS1 HNRNPDL DDX3X HNRNPR	3.30e-05	711	10	4	33022573
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	KHDRBS1 HNRNPDL DDX3X	3.40e-05	232	10	3	25515538
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	KHDRBS1 DDX3X HNRNPR	3.48e-05	234	10	3	36243803
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	KHDRBS1 DDX3X HNRNPR	4.00e-05	245	10	3	35652658
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	KHDRBS1 HNRNPDL FAM98A DDX3X	4.15e-05	754	10	4	35906200
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	HNRNPDL DDX3X HNRNPR	4.24e-05	250	10	3	33536335
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	HNRNPDL DDX3X HNRNPR	4.66e-05	258	10	3	37794589
Pubmed	Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.	KHDRBS1 DDX3X HNRNPR	5.27e-05	269	10	3	30442662
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	HNRNPDL DDX3X HNRNPR DDX3Y	5.30e-05	803	10	4	36517590
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	HNRNPDL HNRNPR DDX3Y	5.39e-05	271	10	3	32433965
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	KHDRBS1 DDX3X HNRNPR	5.57e-05	274	10	3	34244482
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	KHDRBS1 FAM98A DDX3X HNRNPR	6.52e-05	847	10	4	35850772
Pubmed	LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.	KHDRBS1 DDX3X HNRNPR	9.41e-05	327	10	3	31409639
Pubmed	Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.	FAM98A DDX3X	9.79e-05	52	10	2	26265008
Pubmed	HDAC6 activity is not required for basal autophagic flux in metastatic prostate cancer cells.	DDX3X HNRNPR	9.79e-05	52	10	2	26643866
Pubmed	NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.	HNRNPDL DDX3X HNRNPR	9.93e-05	333	10	3	32665550
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	KHDRBS1 DDX3X HNRNPR DDX3Y	1.01e-04	949	10	4	36574265
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	HNRNPDL DDX3X HNRNPR	1.02e-04	336	10	3	31253590
Interaction	TRIM31 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR	2.46e-08	454	10	6	int:TRIM31
Interaction	MIR20A interactions	FAM98A DDX3X HNRNPR DDX3Y	3.46e-08	74	10	4	int:MIR20A
Interaction	MIR98 interactions	FAM98A DDX3X HNRNPR DDX3Y	4.28e-08	78	10	4	int:MIR98
Interaction	MIR143 interactions	FAM98A DDX3X HNRNPR DDX3Y	4.75e-08	80	10	4	int:MIR143
Interaction	MIR106A interactions	FAM98A DDX3X HNRNPR DDX3Y	5.51e-08	83	10	4	int:MIR106A
Interaction	MIR7-2 interactions	FAM98A DDX3X HNRNPR DDX3Y	5.79e-08	84	10	4	int:MIR7-2
Interaction	MIR31 interactions	FAM98A DDX3X HNRNPR DDX3Y	5.79e-08	84	10	4	int:MIR31
Interaction	MIR107 interactions	FAM98A DDX3X HNRNPR DDX3Y	6.07e-08	85	10	4	int:MIR107
Interaction	MIR18B interactions	FAM98A DDX3X HNRNPR DDX3Y	6.07e-08	85	10	4	int:MIR18B
Interaction	SMC5 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR DDX3Y	7.63e-08	1000	10	7	int:SMC5
Interaction	MIR19B2 interactions	FAM98A DDX3X HNRNPR DDX3Y	9.12e-08	94	10	4	int:MIR19B2
Interaction	MIRLET7F1 interactions	FAM98A DDX3X HNRNPR DDX3Y	9.12e-08	94	10	4	int:MIRLET7F1
Interaction	MIR363 interactions	FAM98A DDX3X HNRNPR DDX3Y	1.04e-07	97	10	4	int:MIR363
Interaction	MIR128-2 interactions	FAM98A DDX3X HNRNPR DDX3Y	1.12e-07	99	10	4	int:MIR128-2
Interaction	MIRLET7B interactions	FAM98A DDX3X HNRNPR DDX3Y	1.22e-07	101	10	4	int:MIRLET7B
Interaction	MIRLET7D interactions	FAM98A DDX3X HNRNPR DDX3Y	1.22e-07	101	10	4	int:MIRLET7D
Interaction	MIR25 interactions	FAM98A DDX3X HNRNPR DDX3Y	1.22e-07	101	10	4	int:MIR25
Interaction	MIR7-1 interactions	FAM98A DDX3X HNRNPR DDX3Y	1.32e-07	103	10	4	int:MIR7-1
Interaction	MIR15B interactions	FAM98A DDX3X HNRNPR DDX3Y	1.32e-07	103	10	4	int:MIR15B
Interaction	MIR34A interactions	FAM98A DDX3X HNRNPR DDX3Y	1.37e-07	104	10	4	int:MIR34A
Interaction	BRD7 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR	1.84e-07	637	10	6	int:BRD7
Interaction	MIRLET7G interactions	FAM98A DDX3X HNRNPR DDX3Y	2.21e-07	117	10	4	int:MIRLET7G
Interaction	FUS interactions	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR	5.08e-07	757	10	6	int:FUS
Interaction	CRY2 interactions	KHDRBS1 HNRNPDL DDX3X DDX3Y	1.67e-06	194	10	4	int:CRY2
Interaction	RBM14 interactions	KHDRBS1 HNRNPDL DDX3X SS18 HNRNPR	3.44e-06	553	10	5	int:RBM14
Interaction	MIR138-1 interactions	FAM98A DDX3X HNRNPR	4.34e-06	68	10	3	int:MIR138-1
Interaction	MIR9-3 interactions	FAM98A DDX3X HNRNPR	4.73e-06	70	10	3	int:MIR9-3
Interaction	LARP7 interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR DDX3Y RBMXL3	4.85e-06	1113	10	6	int:LARP7
Interaction	MIR140 interactions	FAM98A DDX3X HNRNPR	4.94e-06	71	10	3	int:MIR140
Interaction	MIR29B1 interactions	FAM98A DDX3X HNRNPR	5.37e-06	73	10	3	int:MIR29B1
Interaction	MIR18A interactions	FAM98A DDX3X HNRNPR	5.37e-06	73	10	3	int:MIR18A
Interaction	MIR15A interactions	FAM98A DDX3X HNRNPR	5.83e-06	75	10	3	int:MIR15A
Interaction	MIR16-1 interactions	FAM98A DDX3X HNRNPR	6.07e-06	76	10	3	int:MIR16-1
Interaction	MIR7-3 interactions	FAM98A DDX3X HNRNPR	6.07e-06	76	10	3	int:MIR7-3
Interaction	MIR199A2 interactions	FAM98A DDX3X HNRNPR	6.07e-06	76	10	3	int:MIR199A2
Interaction	MIR9-2 interactions	FAM98A DDX3X HNRNPR	6.31e-06	77	10	3	int:MIR9-2
Interaction	MIR200A interactions	FAM98A DDX3X HNRNPR	6.31e-06	77	10	3	int:MIR200A
Interaction	MIR222 interactions	FAM98A DDX3X HNRNPR	6.82e-06	79	10	3	int:MIR222
Interaction	MIR34C interactions	FAM98A DDX3X HNRNPR	6.82e-06	79	10	3	int:MIR34C
Interaction	MIR1-2 interactions	FAM98A DDX3X HNRNPR	6.82e-06	79	10	3	int:MIR1-2
Interaction	MIR145 interactions	FAM98A DDX3X HNRNPR	7.36e-06	81	10	3	int:MIR145
Interaction	MIR10B interactions	FAM98A DDX3X HNRNPR	7.63e-06	82	10	3	int:MIR10B
Interaction	MIR200B interactions	FAM98A DDX3X HNRNPR	8.21e-06	84	10	3	int:MIR200B
Interaction	MIR199A1 interactions	FAM98A DDX3X HNRNPR	8.21e-06	84	10	3	int:MIR199A1
Interaction	MIR16-2 interactions	FAM98A DDX3X HNRNPR	8.51e-06	85	10	3	int:MIR16-2
Interaction	MIR93 interactions	FAM98A DDX3X HNRNPR	8.51e-06	85	10	3	int:MIR93
Interaction	MIR9-1 interactions	FAM98A DDX3X HNRNPR	8.51e-06	85	10	3	int:MIR9-1
Interaction	MIR17 interactions	FAM98A DDX3X HNRNPR	8.51e-06	85	10	3	int:MIR17
Interaction	RC3H2 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	8.59e-06	667	10	5	int:RC3H2
Interaction	MIR20B interactions	FAM98A DDX3X HNRNPR	8.81e-06	86	10	3	int:MIR20B
Interaction	MIR29A interactions	FAM98A DDX3X HNRNPR	9.12e-06	87	10	3	int:MIR29A
Interaction	MIR141 interactions	FAM98A DDX3X HNRNPR	9.44e-06	88	10	3	int:MIR141
Interaction	MIR29C interactions	FAM98A DDX3X HNRNPR	9.77e-06	89	10	3	int:MIR29C
Interaction	MIR221 interactions	FAM98A DDX3X HNRNPR	1.01e-05	90	10	3	int:MIR221
Interaction	MIR92A2 interactions	FAM98A DDX3X HNRNPR	1.01e-05	90	10	3	int:MIR92A2
Interaction	MIR200C interactions	FAM98A DDX3X HNRNPR	1.04e-05	91	10	3	int:MIR200C
Interaction	MIR128-1 interactions	FAM98A DDX3X HNRNPR	1.08e-05	92	10	3	int:MIR128-1
Interaction	MIR155 interactions	FAM98A DDX3X HNRNPR	1.08e-05	92	10	3	int:MIR155
Interaction	ATXN2 interactions	KHDRBS1 FAM98A DDX3X HNRNPR	1.10e-05	312	10	4	int:ATXN2
Interaction	MIR214 interactions	FAM98A DDX3X HNRNPR	1.12e-05	93	10	3	int:MIR214
Interaction	MIR205 interactions	FAM98A DDX3X HNRNPR	1.12e-05	93	10	3	int:MIR205
Interaction	MIRLET7A2 interactions	FAM98A DDX3X HNRNPR	1.23e-05	96	10	3	int:MIRLET7A2
Interaction	SYNCRIP interactions	KHDRBS1 HNRNPDL DDX3X SS18 HNRNPR	1.25e-05	721	10	5	int:SYNCRIP
Interaction	MIRLET7C interactions	FAM98A DDX3X HNRNPR	1.27e-05	97	10	3	int:MIRLET7C
Interaction	MIR21 interactions	FAM98A DDX3X HNRNPR	1.27e-05	97	10	3	int:MIR21
Interaction	MIRLET7F2 interactions	FAM98A DDX3X HNRNPR	1.27e-05	97	10	3	int:MIRLET7F2
Interaction	C9orf72 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	1.30e-05	1319	10	6	int:C9orf72
Interaction	MIR106B interactions	DDX3X HNRNPR DDX3Y	1.31e-05	98	10	3	int:MIR106B
Interaction	CUL4B interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR RBMXL3	1.31e-05	728	10	5	int:CUL4B
Interaction	MIR19A interactions	FAM98A DDX3X HNRNPR	1.39e-05	100	10	3	int:MIR19A
Interaction	MIRLET7A3 interactions	FAM98A DDX3X HNRNPR	1.47e-05	102	10	3	int:MIRLET7A3
Interaction	MIR19B1 interactions	FAM98A DDX3X HNRNPR	1.56e-05	104	10	3	int:MIR19B1
Interaction	CHD3 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	1.59e-05	757	10	5	int:CHD3
Interaction	MYCN interactions	KHDRBS1 HNRNPDL FAM98A DDX3X SS18 HNRNPR	1.64e-05	1373	10	6	int:MYCN
Interaction	MIRLET7E interactions	FAM98A DDX3X HNRNPR	1.65e-05	106	10	3	int:MIRLET7E
Interaction	MIRLET7A1 interactions	FAM98A DDX3X HNRNPR	1.75e-05	108	10	3	int:MIRLET7A1
Interaction	BTRC interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	1.78e-05	775	10	5	int:BTRC
Interaction	MIR34B interactions	FAM98A DDX3X HNRNPR	1.85e-05	110	10	3	int:MIR34B
Interaction	RALY interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	1.85e-05	356	10	4	int:RALY
Interaction	RECQL4 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	1.92e-05	1412	10	6	int:RECQL4
Interaction	MIRLET7I interactions	FAM98A DDX3X HNRNPR	2.06e-05	114	10	3	int:MIRLET7I
Interaction	CIT interactions	KHDRBS1 HNRNPDL FAM98A HNRNPR DDX3Y RBMXL3	2.24e-05	1450	10	6	int:CIT
Interaction	MKRN2 interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	2.51e-05	385	10	4	int:MKRN2
Interaction	KHDRBS2 interactions	KHDRBS1 HNRNPDL HNRNPR	2.98e-05	129	10	3	int:KHDRBS2
Interaction	EIF4B interactions	HNRNPDL FAM98A DDX3X DDX3Y	2.98e-05	402	10	4	int:EIF4B
Interaction	CAND1 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	3.55e-05	894	10	5	int:CAND1
Interaction	NUDCD2 interactions	HNRNPDL DDX3X HNRNPR DDX3Y	3.67e-05	424	10	4	int:NUDCD2
Interaction	MALAT1 interactions	KHDRBS1 DDX3X HNRNPR	3.72e-05	139	10	3	int:MALAT1
Interaction	DDX17 interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	3.74e-05	426	10	4	int:DDX17
Interaction	FXR2 interactions	KHDRBS1 FAM98A DDX3X HNRNPR	3.88e-05	430	10	4	int:FXR2
Interaction	IL7R interactions	HNRNPDL DDX3X HNRNPR	3.88e-05	141	10	3	int:IL7R
Interaction	HEXIM1 interactions	HNRNPDL FAM98A DDX3X HNRNPR DDX3Y	3.93e-05	913	10	5	int:HEXIM1
Interaction	DAZL interactions	HNRNPDL FAM98A HNRNPR	4.22e-05	145	10	3	int:DAZL
Interaction	SNRPC interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	4.24e-05	440	10	4	int:SNRPC
Interaction	PRMT1 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	4.27e-05	929	10	5	int:PRMT1
Interaction	OGT interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	4.76e-05	950	10	5	int:OGT
Interaction	TNIP2 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	4.81e-05	952	10	5	int:TNIP2
Interaction	RBMX interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	5.09e-05	461	10	4	int:RBMX
Interaction	FBXW11 interactions	KHDRBS1 HNRNPDL DDX3X HNRNPR	5.62e-05	473	10	4	int:FBXW11
Interaction	SNRNP70 interactions	KHDRBS1 HNRNPDL FAM98A DDX3X HNRNPR	5.64e-05	984	10	5	int:SNRNP70
GeneFamily	RNA binding motif containing	HNRNPDL HNRNPR RBMXL3	8.64e-05	213	8	3	725
GeneFamily	DEAD-box helicases	DDX3X DDX3Y	1.46e-04	42	8	2	499
Coexpression	BIDUS_METASTASIS_UP	KHDRBS1 HNRNPDL HNRNPR	6.79e-05	221	10	3	M15866
Coexpression	HAY_BONE_MARROW_PRO_B	KHDRBS1 HNRNPDL HNRNPR	1.75e-04	304	10	3	M39208
Coexpression	IKEDA_MIR1_TARGETS_UP	DDX3X HNRNPR	1.85e-04	54	10	2	MM927
Coexpression	IKEDA_MIR1_TARGETS_UP	DDX3X HNRNPR	1.85e-04	54	10	2	M2372
Coexpression	FISCHER_DREAM_TARGETS	KHDRBS1 HNRNPDL SS18 HNRNPR	3.26e-04	969	10	4	M149
Coexpression	SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	HNRNPDL HNRNPR	4.28e-04	82	10	2	M9224
Coexpression	ENK_UV_RESPONSE_KERATINOCYTE_DN	HNRNPDL HNRNPR DDX3Y	6.69e-04	481	10	3	M3898
Coexpression	ONKEN_UVEAL_MELANOMA_DN	HNRNPDL DDX3X SS18	9.02e-04	533	10	3	M2605
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	HNRNPDL DDX3X SS18 HNRNPR	9.66e-04	1290	10	4	M80
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_DN	HNRNPR DDX3Y	1.01e-03	126	10	2	M9362
Coexpression	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	HNRNPDL DDX3X HNRNPR	1.08e-03	568	10	3	M4023
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_DN	HNRNPR DDX3Y	1.15e-03	135	10	2	MM753
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	KHDRBS1 DDX3X HNRNPR	1.19e-03	587	10	3	M40869
Coexpression	BROWNE_HCMV_INFECTION_14HR_UP	DDX3X DDX3Y	1.53e-03	156	10	2	M17225
Coexpression	GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP	SS18 HNRNPR	1.65e-03	162	10	2	M6673
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	KHDRBS1 HNRNPDL DDX3X DDX3Y	1.66e-03	1492	10	4	M40023
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	DDX3X HNRNPR	1.74e-03	166	10	2	M8129
Coexpression	GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	HNRNPDL DDX3Y	1.82e-03	170	10	2	M6697
Coexpression	SNF5_DN.V1_UP	DDX3X DDX3Y	1.88e-03	173	10	2	M2718
Coexpression	GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP	IBSP FRMD7	2.33e-03	193	10	2	M9056
Coexpression	GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP	HNRNPDL DDX3Y	2.38e-03	195	10	2	M3124
Coexpression	GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN	HNRNPDL FAM98A	2.46e-03	198	10	2	M8152
Coexpression	GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP	IBSP DDX3X	2.46e-03	198	10	2	M8866
Coexpression	GSE3982_NEUTROPHIL_VS_BCELL_DN	KHDRBS1 SS18	2.46e-03	198	10	2	M5521
Coexpression	GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	HNRNPDL HNRNPR	2.48e-03	199	10	2	M3175
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	HNRNPDL DDX3X	2.48e-03	199	10	2	M9501
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN	HNRNPDL SS18	2.48e-03	199	10	2	M4055
Coexpression	GSE27786_NKTCELL_VS_ERYTHROBLAST_UP	KHDRBS1 DDX3X	2.48e-03	199	10	2	M4865
Coexpression	GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP	HNRNPDL DDX3X	2.48e-03	199	10	2	M8298
Coexpression	GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP	FAM98A DDX3X	2.48e-03	199	10	2	M8000
Coexpression	GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP	HNRNPDL FAM98A	2.50e-03	200	10	2	M3707
Coexpression	GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP	SS18 HNRNPR	2.50e-03	200	10	2	M3507
Coexpression	GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN	HNRNPDL DDX3X	2.50e-03	200	10	2	M8331
Coexpression	GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP	DDX3X DDX3Y	2.50e-03	200	10	2	M9663
Coexpression	GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	KHDRBS1 HNRNPDL	2.50e-03	200	10	2	M8597
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP	SS18 HNRNPR	2.50e-03	200	10	2	M9942
Coexpression	GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP	KHDRBS1 SS18	2.50e-03	200	10	2	M7789
Coexpression	GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP	HNRNPDL DDX3X	2.50e-03	200	10	2	M3774
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN	KHDRBS1 SS18	2.50e-03	200	10	2	M5991
Coexpression	GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN	KHDRBS1 HNRNPR	2.50e-03	200	10	2	M6603
Coexpression	GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	DDX3X HNRNPR	2.50e-03	200	10	2	M5783
Coexpression	GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP	DDX3X HNRNPR	2.50e-03	200	10	2	M5777
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN	HNRNPDL HNRNPR	2.50e-03	200	10	2	M3841
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP	DDX3X DDX3Y	2.50e-03	200	10	2	M8489
Coexpression	GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN	HNRNPDL FAM98A	2.50e-03	200	10	2	M7618
Coexpression	GSE27434_WT_VS_DNMT1_KO_TREG_DN	HNRNPR DDX3Y	2.50e-03	200	10	2	M9621
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN	HNRNPDL FAM98A	2.50e-03	200	10	2	M9864
Coexpression	GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	KHDRBS1 HNRNPDL	2.50e-03	200	10	2	M6587
Coexpression	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	KHDRBS1 HNRNPDL	2.50e-03	200	10	2	M8765
Coexpression	GSE17721_CTRL_VS_LPS_1H_BMDC_UP	HNRNPDL DDX3Y	2.50e-03	200	10	2	M3683
Coexpression	GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP	FAM98A HNRNPR	2.50e-03	200	10	2	M7805
Coexpression	DESCARTES_ORGANOGENESIS_STROMAL_CELLS	KHDRBS1 DDX3X	2.53e-03	201	10	2	MM3652
Coexpression	HOLLMANN_APOPTOSIS_VIA_CD40_UP	SS18 DDX3Y	2.58e-03	203	10	2	M9695
Coexpression	OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	HNRNPDL DDX3Y	3.13e-03	224	10	2	M12383
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_200	HNRNPR DDX3Y	8.05e-05	29	10	2	gudmap_developingGonad_e16.5_epididymis_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	KHDRBS1 HNRNPDL DDX3Y	1.95e-04	256	10	3	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#4_top-relative-expression-ranked_500	HNRNPR DDX3Y	2.72e-04	53	10	2	gudmap_developingGonad_P2_epididymis_500_k4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500	HNRNPR DDX3Y	3.96e-04	64	10	2	gudmap_developingGonad_e18.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000	DDX3X HNRNPR DDX3Y	4.85e-04	349	10	3	gudmap_developingGonad_P2_testes_1000_k2
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000	DDX3X HNRNPR DDX3Y	6.12e-04	378	10	3	gudmap_developingGonad_e16.5_testes_1000_k3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_500	HNRNPR DDX3Y	7.99e-04	91	10	2	gudmap_developingGonad_e16.5_epididymis_500_k4
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	KHDRBS1 HNRNPDL HNRNPR	1.00e-05	199	10	3	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Stmn2))\|Striatum / BrainAtlas - Mouse McCarroll V32	KHDRBS1 IBSP	1.76e-04	90	10	2	7efc3437489c8587b9805547da1095f50d20cf6d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Slc17a8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IBSP FRMD7	1.92e-04	94	10	2	0dc7e645149fa4255cbe1d288524a1ca7ab66376
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IBSP FRMD7	2.31e-04	103	10	2	780a94c27ac3eb138a9f284251ae094d3e97ce71
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IBSP FRMD7	2.83e-04	114	10	2	9f0c8dfd740d50448a6c91a00e7bae4dfc9b3302
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IBSP FRMD7	2.93e-04	116	10	2	605bd4fdf547cc41783e99cd78425760ef6461ef
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IBSP FRMD7	3.84e-04	133	10	2	840e8240db29cd21ed9830843c0fa6d65b8f300a
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KHDRBS1 HNRNPR	4.02e-04	136	10	2	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KHDRBS1 HNRNPR	4.02e-04	136	10	2	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	HNRNPR DDX3Y	5.28e-04	156	10	2	5df19a235843829f5a1a90ca21b0964ef8b4e115
ToppCell	Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	HNRNPR DDX3Y	5.28e-04	156	10	2	029ba0832ee9c4a2c85620e4df2260e02d86b45c
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2\|TCGA-Lung / Sample_Type by Project: Shred V9	KHDRBS1 HNRNPR	5.41e-04	158	10	2	9dea15b28f64206bac0e785df6f36a2cc9010ac7
ToppCell	IIF\|World / Disease, Lineage and Cell Type	HNRNPDL DDX3Y	6.19e-04	169	10	2	ebf726f725079317ad67c2f754748b4112607277
ToppCell	3'_v3-lymph-node_spleen\|World / Manually curated celltypes from each tissue	DDX3X DDX3Y	6.33e-04	171	10	2	7aae88da5b37c20f10118325a048f08906be994c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-2_PVALB_TAC1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IBSP FRMD7	6.86e-04	178	10	2	1985271984e6747941c8d2097d9c58f0260f021a
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KHDRBS1 HNRNPR	7.01e-04	180	10	2	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	droplet-Marrow-BM\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPDL DDX3Y	7.09e-04	181	10	2	4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPDL DDX3X	7.17e-04	182	10	2	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	IBSP FRMD7	7.17e-04	182	10	2	ba066ff9029cc052b76e2330ec168cb2e9b7e498
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	IBSP FRMD7	7.25e-04	183	10	2	27a57cd8ea924420e182f3d72f5b29b00dea8fa0
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE\|Hippocampus / BrainAtlas - Mouse McCarroll V32	KHDRBS1 HNRNPR	7.65e-04	188	10	2	8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	HNRNPDL DDX3X	7.73e-04	189	10	2	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNRNPDL IBSP	7.73e-04	189	10	2	3169476f98b7385706cb618c9ad64ae83a290ef0
ToppCell	H1299-infected-SARSCoV1\|infected / Cell line, Condition and Strain	KHDRBS1 HNRNPR	7.81e-04	190	10	2	f7bfeefc0f30f81710a5ddd979f19b0c910c4a42
ToppCell	COVID-19_Severe-CD8+_T_activated\|World / disease group, cell group and cell class	HNRNPDL DDX3Y	8.05e-04	193	10	2	ddc1db516568e03be8e82b2ca770c67756418185
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX3X DDX3Y	8.14e-04	194	10	2	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX3X DDX3Y	8.14e-04	194	10	2	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX3X DDX3Y	8.14e-04	194	10	2	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DDX3X DDX3Y	8.14e-04	194	10	2	5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a
ToppCell	facs-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX3X DDX3Y	8.22e-04	195	10	2	79114b3c78cc15c413bb58f0673e7215b784a9b6
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	DDX3X DDX3Y	8.22e-04	195	10	2	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPDL DDX3Y	8.22e-04	195	10	2	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	HNRNPDL DDX3X	8.30e-04	196	10	2	528622874692d7d65c905738b078ab53acef5846
ToppCell	Megakaryocytic-erythropoietic-MEP-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	KHDRBS1 HNRNPDL	8.30e-04	196	10	2	4e97010185fa9392da8f69e7b2a7395bf063f8ff
ToppCell	COVID-19_Severe\|World / Disease condition and Cell class	HNRNPR DDX3Y	8.30e-04	196	10	2	450ac2aff89c5ca73b8bfbc80663e03be066931f
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HNRNPDL DDX3Y	8.30e-04	196	10	2	c647ce58de4c5bb4ceb1123690e637eae4ae1b82
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KHDRBS1 DDX3X	8.30e-04	196	10	2	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	Megakaryocytic-erythropoietic-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	KHDRBS1 HNRNPDL	8.30e-04	196	10	2	f90e7fe3a7b2fff30d01a25cc500876861c2e4f1
ToppCell	Control-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	DDX3X DDX3Y	8.39e-04	197	10	2	eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.39e-04	197	10	2	7290f05d0b8465637420119941bcbf2fae44a7e4
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	DDX3X DDX3Y	8.39e-04	197	10	2	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.39e-04	197	10	2	106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCell	10x5'v1-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.39e-04	197	10	2	31dfd9842410b5c629f39b5130233995dceb0aef
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNRNPDL IBSP	8.47e-04	198	10	2	148f5fee19ea8dff7f2de4ca69c3b03e5221985d
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HNRNPDL DDX3X	8.47e-04	198	10	2	ec115c4a5dbc54206c72140aa0c8d6a7c29c5563
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	KHDRBS1 DDX3Y	8.56e-04	199	10	2	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Early_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	KHDRBS1 HNRNPDL	8.56e-04	199	10	2	d67f5ae05daf942fb79f5b962021f37f4e275f4d
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	LPS_only\|World / Treatment groups by lineage, cell group, cell type	HNRNPDL DDX3X	8.56e-04	199	10	2	852cf595c2255983cff9045f2bb746d4391cf5ba
ToppCell	3'-GW_trimst-1\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KHDRBS1 HNRNPDL	8.56e-04	199	10	2	ecfb6381e2971a3e355e661a6df0021914485e74
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	KHDRBS1 HNRNPR	8.56e-04	199	10	2	6f159c1215439ec22374903124085746fa8da333
ToppCell	Enterocyte_Progenitors\|World / shred on cell type and cluster	KHDRBS1 HNRNPDL	8.56e-04	199	10	2	776bcc887927dea9ebd76ec4338ce2225c319c2c
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.56e-04	199	10	2	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	KHDRBS1 DDX3Y	8.56e-04	199	10	2	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.64e-04	200	10	2	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	KHDRBS1 HNRNPDL	8.64e-04	200	10	2	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SS18 DDX3Y	8.64e-04	200	10	2	f0c338877e39226a90c4effe12f6501d33542a73
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.64e-04	200	10	2	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	MS-IIF\|MS / Disease, condition lineage and cell class	HNRNPDL DDX3Y	8.64e-04	200	10	2	221f59edcfc18baece13184c2552d26022228146
ToppCell	wk_08-11\|World / Celltypes from embryonic and fetal-stage human lung	KHDRBS1 HNRNPDL	8.64e-04	200	10	2	aa35c33762880a5e030a7e691c425524f7dbff8a
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.64e-04	200	10	2	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	KHDRBS1 HNRNPDL	8.64e-04	200	10	2	48d79c7a9a2d3c10b41e152baf28fb00a4729e48
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPR	8.64e-04	200	10	2	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	facs-Brain_Non-Myeloid-Hippocampus\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SS18 DDX3Y	8.64e-04	200	10	2	fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c
Computational	RNA splicing.	KHDRBS1 HNRNPDL HNRNPR	1.16e-05	65	8	3	MODULE_183
Computational	Neighborhood of HDAC1	KHDRBS1 HNRNPDL HNRNPR	5.63e-05	110	8	3	GNF2_HDAC1
Computational	Neighborhood of CBFB	KHDRBS1 HNRNPDL	2.09e-04	30	8	2	GNF2_CBFB
Computational	Genes in the cancer module 32.	KHDRBS1 HNRNPR DDX3Y	5.74e-04	241	8	3	MODULE_32
Computational	Neighborhood of DENR	KHDRBS1 HNRNPR	6.07e-04	51	8	2	GNF2_DENR
Computational	Neighborhood of SMC1L1	KHDRBS1 HNRNPR	8.96e-04	62	8	2	MORF_SMC1L1
Computational	Neighborhood of DDX5	HNRNPDL DDX3X	9.25e-04	63	8	2	GNF2_DDX5
Computational	Neighborhood of TERF1	KHDRBS1 HNRNPR	1.05e-03	67	8	2	MORF_TERF1
Computational	Neighborhood of KPNB1	KHDRBS1 HNRNPR	1.24e-03	73	8	2	GNF2_KPNB1
Computational	Genes in the cancer module 83.	KHDRBS1 HNRNPR DDX3Y	1.31e-03	320	8	3	MODULE_83
Computational	Neighborhood of APEX1	KHDRBS1 HNRNPR	1.96e-03	92	8	2	GNF2_APEX1
Computational	Neighborhood of UBE2N	KHDRBS1 HNRNPR	2.09e-03	95	8	2	MORF_UBE2N
Computational	Transcription.	KHDRBS1 HNRNPDL	2.13e-03	96	8	2	MODULE_124
Computational	Neighborhood of RRM1	KHDRBS1 HNRNPR	2.41e-03	102	8	2	MORF_RRM1
Computational	Neighborhood of DNMT1	KHDRBS1 HNRNPR	3.20e-03	118	8	2	MORF_DNMT1
Computational	Neighborhood of DAP3	KHDRBS1 HNRNPR	3.26e-03	119	8	2	GNF2_DAP3
Computational	Neighborhood of FBL	KHDRBS1 HNRNPR	4.86e-03	146	8	2	GNF2_FBL
Computational	Neighborhood of CDC10	KHDRBS1 HNRNPR	4.86e-03	146	8	2	MORF_CDC10
Computational	Neighborhood of RFC4	KHDRBS1 HNRNPR	5.19e-03	151	8	2	MORF_RFC4
Computational	Neighborhood of PPP1CC	KHDRBS1 HNRNPR	6.24e-03	166	8	2	MORF_PPP1CC
Computational	Neighborhood of HAT1	KHDRBS1 HNRNPR	6.92e-03	175	8	2	MORF_HAT1
Drug	bromovanin	HNRNPDL DDX3X HNRNPR DDX3Y	1.89e-07	127	10	4	ctd:C515564
Drug	Amoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X SS18	6.07e-05	185	10	3	2620_DN
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; HL60; HT_HG-U133A	HNRNPDL DDX3X SS18	6.78e-05	192	10	3	1271_DN
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; HL60; HG-U133A	HNRNPDL DDX3X HNRNPR	7.21e-05	196	10	3	2043_DN
Drug	PNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A	HNRNPDL DDX3X SS18	7.21e-05	196	10	3	6563_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; HL60; HG-U133A	HNRNPDL DDX3X HNRNPR	7.32e-05	197	10	3	1777_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	KHDRBS1 DDX3X SS18	7.32e-05	197	10	3	6341_UP
Drug	Niflumic acid [4394-00-7]; Up 200; 14.2uM; HL60; HT_HG-U133A	IBSP DDX3X SS18	7.54e-05	199	10	3	2399_UP
Drug	Adana	DDX3X DDX3Y	1.09e-04	36	10	2	CID000117765
Drug	AC1NRA8H	DDX3X DDX3Y	7.59e-04	95	10	2	CID005287756
Drug	Nitroprusside	HNRNPDL IBSP	1.03e-03	111	10	2	ctd:D009599
Drug	carbonyl sulfide	DDX3X DDX3Y	1.13e-03	116	10	2	CID000010039
Drug	heparin pentasaccharide	DDX3X DDX3Y	1.73e-03	144	10	2	CID000444410
Drug	DB04649	FRMD7 SS18	1.83e-03	148	10	2	CID005287847
Drug	Buspirone	KHDRBS1 FAM98A HNRNPR	2.11e-03	622	10	3	ctd:D002065
Drug	Polychlorinated Biphenyls	HNRNPDL FAM98A DDX3Y	2.22e-03	633	10	3	ctd:D011078
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; HL60; HT_HG-U133A	KHDRBS1 DDX3X	2.23e-03	164	10	2	2920_UP
Drug	Emetine dihydrochloride [316-42-7]; Down 200; 7.2uM; HL60; HT_HG-U133A	DDX3X HNRNPR	2.26e-03	165	10	2	2145_DN
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	DDX3X SS18	2.29e-03	166	10	2	4327_UP
Drug	AC1NRA5C	KHDRBS1 HNRNPR	2.51e-03	174	10	2	CID005287709
Drug	Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A	DDX3X SS18	2.51e-03	174	10	2	2456_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A	KHDRBS1 SS18	2.57e-03	176	10	2	6886_UP
Drug	Pyrogallol	HNRNPDL DDX3X	2.62e-03	178	10	2	ctd:D011748
Drug	fisetin; Down 200; 50uM; PC3; HG-U133A	HNRNPDL DDX3X	2.62e-03	178	10	2	579_DN
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A	DDX3X SS18	2.65e-03	179	10	2	3388_DN
Drug	Triamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A	DDX3X SS18	2.65e-03	179	10	2	1819_UP
Drug	Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X	2.68e-03	180	10	2	2859_DN
Drug	Parthenolide [20554-84-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X	2.77e-03	183	10	2	5530_DN
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	HNRNPDL SS18	2.77e-03	183	10	2	2750_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	DDX3X SS18	2.77e-03	183	10	2	4843_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X	2.83e-03	185	10	2	4688_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	DDX3X SS18	2.86e-03	186	10	2	5010_DN
Drug	Cefadroxil [50370-12-2]; Down 200; 11uM; HL60; HT_HG-U133A	DDX3X SS18	2.86e-03	186	10	2	1323_DN
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; HL60; HG-U133A	FAM98A HNRNPR	2.86e-03	186	10	2	1563_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	DDX3X HNRNPR	2.89e-03	187	10	2	4302_DN
Drug	Sulfaphenazole [526-08-9]; Up 200; 12.8uM; PC3; HT_HG-U133A	HNRNPDL SS18	2.89e-03	187	10	2	1794_UP
Drug	C768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA	DDX3X SS18	2.89e-03	187	10	2	973_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	DDX3X HNRNPR	2.92e-03	188	10	2	1421_DN
Drug	Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A	DDX3X SS18	2.92e-03	188	10	2	2161_DN
Drug	Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A	HNRNPDL SS18	2.92e-03	188	10	2	1832_UP
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	DDX3X SS18	2.92e-03	188	10	2	4835_DN
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	KHDRBS1 IBSP	2.92e-03	188	10	2	4386_UP
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	6793_DN
Drug	17-AAG; Up 200; 1uM; PC3; HT_HG-U133A	DDX3X DDX3Y	2.95e-03	189	10	2	4430_UP
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	6750_DN
Drug	Ginkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	4121_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	4271_DN
Drug	Benzbromarone [3562-84-3]; Up 200; 9.4uM; HL60; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	1291_UP
Drug	0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A	HNRNPDL SS18	2.95e-03	189	10	2	3690_DN
Drug	Alprostadil [745-65-3]; Up 200; 11.2uM; PC3; HT_HG-U133A	DDX3X SS18	2.95e-03	189	10	2	4099_UP
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	7439_DN
Drug	Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	3144_DN
Drug	Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	2465_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X	2.98e-03	190	10	2	3379_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	1636_DN
Drug	resveratrol; Down 200; 50uM; MCF7; HG-U133A	HNRNPDL DDX3X	2.98e-03	190	10	2	622_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	6718_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	4582_DN
Drug	Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; PC3; HT_HG-U133A	KHDRBS1 IBSP	2.98e-03	190	10	2	6697_UP
Drug	Nilutamide [63612-50-0]; Down 200; 12.6uM; MCF7; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	5362_DN
Drug	Roxithromycin [80214-83-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	3331_DN
Drug	Azacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A	DDX3X SS18	2.98e-03	190	10	2	4010_DN
Drug	irinotecan	KHDRBS1 HNRNPDL DDX3X	2.99e-03	703	10	3	ctd:C051890
Drug	Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A	DDX3X SS18	3.01e-03	191	10	2	4299_DN
Drug	Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	DDX3X SS18	3.01e-03	191	10	2	6721_DN
Drug	monastrol; Up 200; 20uM; MCF7; HG-U133A	KHDRBS1 HNRNPR	3.01e-03	191	10	2	614_UP
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	DDX3X HNRNPR	3.01e-03	191	10	2	1418_DN
Drug	Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A	KHDRBS1 SS18	3.01e-03	191	10	2	2368_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	DDX3X SS18	3.01e-03	191	10	2	1813_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	HNRNPDL DDX3X	3.04e-03	192	10	2	4288_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	4334_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; MCF7; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	2624_DN
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	3245_DN
Drug	Norethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A	KHDRBS1 SS18	3.04e-03	192	10	2	2383_UP
Drug	Monobenzone [103-16-2]; Down 200; 20uM; PC3; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	6713_DN
Drug	Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; HL60; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	1266_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	2101_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A	HNRNPDL DDX3X	3.04e-03	192	10	2	1661_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	1647_DN
Drug	Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	4816_DN
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; PC3; HT_HG-U133A	KHDRBS1 SS18	3.04e-03	192	10	2	3804_DN
Drug	aspirin, USP; Down 200; 100uM; HL60; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	6164_DN
Drug	Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A	DDX3X SS18	3.04e-03	192	10	2	6752_DN
Drug	Gramine [87-52-5]; Up 200; 23uM; MCF7; HT_HG-U133A	KHDRBS1 DDX3X	3.08e-03	193	10	2	4118_UP
Drug	Spironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A	HNRNPDL HNRNPR	3.08e-03	193	10	2	1380_DN
Drug	Methylergometrine maleate [113-42-8]; Down 200; 8.8uM; PC3; HT_HG-U133A	DDX3X SS18	3.08e-03	193	10	2	6704_DN
Disease	childhood medulloblastoma (implicated_via_orthology)	DDX3X DDX3Y	8.27e-08	2	9	2	DOID:3869 (implicated_via_orthology)
Disease	Sertoli cell-only syndrome (implicated_via_orthology)	DDX3X DDX3Y	4.96e-07	4	9	2	DOID:0050457 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	IBSP DDX3X HNRNPR	3.43e-03	1074	9	3	C0006142
Disease	Intellectual Disability	DDX3X HNRNPR	7.68e-03	447	9	2	C3714756
Disease	Mammary Neoplasms, Human	IBSP HNRNPR	1.05e-02	525	9	2	C1257931
Disease	Mammary Carcinoma, Human	IBSP HNRNPR	1.05e-02	525	9	2	C4704874
Disease	Mammary Neoplasms	IBSP HNRNPR	1.05e-02	527	9	2	C1458155
Disease	Breast Carcinoma	IBSP HNRNPR	1.10e-02	538	9	2	C0678222

Protein segments in the cluster

Peptide	Gene	Start	Entry
NYGYGQGYADYSGQQ	HNRNPDL	386	O14979
GFYNSDGYGGNYNSQ	DDX3X	641	O00571
LAYGGGYYQNVNGVH	FRMD7	356	Q6ZUT3
QGGDYSGNYGYNNDN	HNRNPR	606	O43390
QGDSEYYDYGHGEVQ	KHDRBS1	391	Q07666
YNSDGYGGNYNSQGV	DDX3Y	641	O15523
GYQGGGYQQDNRYQD	FAM98A	436	Q8NCA5
KGQGYDGYDGQNYYH	IBSP	301	P21815
YGQSHHYGGEGRYEE	RBMXL3	411	Q8N7X1
GQEDYYGDQYSHGGQ	SS18	266	Q15532
DSSQHYYEGGNSQYG	SS18	316	Q15532